Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

J.B. Chemicals & Pharmaceuticals Lt Call Transcript 2025

Feb 5, 2025

63696_rns_2025-02-05_76994c9b-219d-41ce-b634-249ac6d0b3f7.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [596 x 140] intentionally omitted <==

February 5, 2025

BSE Ltd. Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400 001

BSE Scrip Code: 506943

Stock Symbol: JBCHEPHARM

Dear Sir,

Subject: Audio recording of Investors/analysts call with Management

Ref.: Disclosure under regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 30 read with Schedule III and Regulation 46(2)(oa) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the audio recording of the conference call for investors and analysts scheduled on February 5, 2025 at 12.00 noon IST in relation to results and developments for the third quarter ended December 31, 2024 is available on the website of the Company.

The link to access the same is: https://jbpharma.com/download/q3-fy25-earnings-callaudio/?wpdmdl=10220&refresh=67a3298d4ae681738746253

We request you to take this on record.

Thanking you,

Yours faithfully,

For J.B. Chemicals & Pharmaceuticals Limited

Sandeep Phadnis Sandeep Anil Phadnis Digitally signed by Sandeep Anil Phadnis DN: c=IN, o=Personal, title=8434, pseudonym=108F69E4E868E4C1147674C13B2684AC9CDD8E36, 2.5.4.20=715f7603f235e5d1d74002aec03d24cf432efd8296e6e1c3c0c80534a90c098e, postalCode=411038, st=Maharashtra, serialNumber=CC500FDD638E71336FC58B204E2BA05EA7C4ADE49B8FE438E8F254C300DEC735, cn=Sandeep Anil Phadnis Date: 2025.02.05 14:40:01 +05'30' Vice President – Secretarial & Company Secretary

==> picture [595 x 154] intentionally omitted <==